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Abstract
Background: We previously identified the 67-kDa laminin receptor (67LR) as the cell-surface receptor conferring the major
green tea polyphenol (–)-epigallocatechin-3-O-gallate (EGCG) responsiveness to cancer cells. However, the underlying
mechanism for interaction between EGCG and 67LR remains unclear. In this study, we investigated the possible role of
EGCG-67LR interaction responsible for its bioactivities.
Methodology/Principal Findings: We synthesized various peptides deduced from the extracellular domain corresponding
to the 102-295 region of human 67LR encoding a 295-amino acid. The neutralizing activity of these peptides toward EGCG
cell-surface binding and inhibition of cancer cell growth were assayed. Both activities were inhibited by a peptide
containing the 10-amino acid residues, IPCNNKGAHS, corresponding to residues 161-170. Furthermore, mass spectrometric
analysis revealed the formation of a EGCG-LR161-170 peptide complex. A study of the amino acid deletion/replacement of
the peptide LR161-170 indicated that the 10-amino acid length and two basic amino acids, K
166 and H
169, have a critical role
in neutralizing EGCG’s activities. Moreover, neutralizing activity against the anti-proliferation action of EGCG was observed
in a recombinant protein of the extracellular domain of 67LR, and this effect was abrogated by a deletion of residues 161-
170. These findings support that the 10 amino-acid sequence, IPCNNKGAHS, might be the functional domain responsible for
the anti-cancer activity of EGCG.
Conclusions/Significance: Overall, our results highlight the nature of the EGCG-67LR interaction and provide novel
structural insights into the understanding of 67LR-mediated functions of EGCG, and could aid in the development of
potential anti-cancer compounds for chemopreventive or therapeutic uses that can mimic EGCG-67LR interactions.
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Introduction
Green tea has been shown to have cancer preventive activity in
a variety of organ sites in animal models [1–3] and humans [4].
Among the green tea constituents, (–)-epigallocatechin-3-O-gallate
(EGCG) is the most abundant and most active constituent in
inhibiting experimental carcinogenesis and related reactions.
Although many mechanisms for the anti-cancer activities of
EGCG at concentrations of more than 10 mM, concentrations that
are much higher than those observed in plasma or tissues, have
been proposed based mainly on studies in cell lines, it is still not
clear which EGCG-induced molecular events and potential
molecular targets are responsible for its cancer-preventive activity
in vivo [5]. Recently we have identified the 67-kDa laminin
receptor (67LR) as a cell-surface EGCG receptor that mediates the
anti-cancer action, cancer cell growth inhibition, of a physiologi-
cally relevant EGCG [6], and others showed that RNAi-mediated
silencing of 67LR results in abrogation of EGCG-induced
apoptosis in myeloma cells [7].
The 67LR is a non-integrin cell-surface receptor for laminin
with high affinity [8]. This receptor appears to be very peculiar
since so far only a full-length gene encoding a 37-kDa precursor
protein of 295-amino acids has been isolated and the mechanism
by which the precursor reaches the mature 67-kDa form still
remains unclear [9]. A hydrophobic segment (residues 86–101)
has been hypothesized to act as a transmembrane domain, and
the C-terminal domain of the receptor is thought to be involved in
the interaction with laminin [10]. The evolutionary analysis of the
sequence identified as the laminin-binding site in the human
protein suggested that the acquisition of the laminin-binding
capability is linked to the 173–178 region of the extracellular
domain (residues 102–295), which appeared during evolution
concomitantly with laminin [11]. Its role as a laminin receptor
makes it an important molecule in cell adhesion to the basement
membrane and in the metastasis of tumor cells [12]. Down-
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impedes invasion of fibrosarcoma cells, suggesting that the
receptor plays a key role in tumor metastasis [13]. An increase
in 67LR expression as compared with the corresponding normal
tissue has been found in a variety of common cancers, including
breast, cervical, colon, lung, ovary, pancreatic, and prostate
carcinomas [14,15]. Interestingly, the 67LR is the molecule
showing a good correlation between the expression pattern of
67LR and EGCG susceptibility in both human normal cells and
myeloma patient samples [7]. Thus, it was postulated that 67LR
plays a significant role in tumor progression and studies conducted
to define the function of 67LR could provide a new approach to
cancer prevention. Most recently, we showed an abrogation of
EGCG-induced tumor cell growth inhibition in C57BL/6N mice
challenged with 67LR or its downstream signaling molecules,
eukaryotic translation elongation factor 1A or myosin phosphatase
targeting subunit 1, -knockdowned B16 cells [16]. This is the first
report demonstrating the involvement of the EGCG target and its
downstream signaling molecules in anti-cancer activity of EGCG
in vivo. This finding suggests that 67LR and its downstream
signaling molecules are ‘‘authentic molecular targets’’, which
determine the efficacy of the cancer-preventive activity of EGCG
in a tumor model and have important implications for de-
velopment and use of EGCG as a cancer-preventive agent.
In recent studies on the anti-cancer action of EGCG, a suggested
mechanism of interaction between EGCG and its binding-proteins
has been reported [5]. 67LR interacts with many ligands including
laminin, cellular pathogenic prion proteins, cytotoxic necrotizing
factor 1 from Escherichia coli, Sindbis virus, Venezuelan equine
encephalitis virus, Dengue virus, and adeno-associated virus, but
the underlying interaction mechanism has not been elucidated
[8,9,17–22]. The crystal structure of the partial domain of human
67LR has been reported, and the results suggested that this finding
may provide insights into its function and facilitate the design of
novel therapeutics targeting 67LR [23]. However, a possible role
of the interaction of EGCG with 67LR still remains unclear.
In this study, our aim is to investigate a potential mechanism of
the EGCG-67LR interaction responsible for the bioactivities of
EGCG. We performed the neutralizing activity assay using various
peptides deduced from the extracellular domain corresponding to
the 102–295 region of human 67LR. Only a stretch of 10-amino
acids, 161 to 170, IPCNNKGAHS, plays a critical role in
neutralizing EGCG’s abilities such as the cell-surface binding and
its inhibitory effects on cancer cell growth. This result indicates
that residues 161-170 contribute to 67LR-mediated cellular
response to EGCG stimulation. This is the first evidence indicating
the existence of a potential EGCG sensing motif on 67LR.
Materials and Methods
Reagents
(–)-Epigallocatechin-3-O-gallate (EGCG), catalase, and super-
oxide dismutase (SOD) were purchased from Sigma Chemical Co.
(St. Louis, MO). Synthesized peptides, 9-20-amino acid residue
peptides deduced from the extracellular domain corresponding to
the 102-295 region of the human 67LR encoding a 295-amino
acid were purchased from Thermo Electron GmbH (Ulm,
Germany). The anti-human LR polyclonal (F-18) antibody was
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
The anti-human LR monoclonal antibody (MLuC5) was pur-
chased from NEOMARKERS (Fremont, CA). Anti-b-actin
antibody was obtained from Sigma Chemical Co. (St. Louis,
MO). Restriction enzymes were purchased from Fermentas
International, Inc (Burlington, Canada). The plasmid vectors used
were pTARGET
TM and pET-30a(+) from Promega Corporation
(Madison, WI) and Merck Biosciences (San Diego, CA), re-
spectively. E. coli strain JM109 was used as a host for cloning E. coli
strain BL21 (DE3) (Agilent Technologies, Inc., Santa Clara, CA)
was used as a host for the expression of recombinant proteins.
Cells and Cell Proliferation Test
To obtain the cells that were highly sensitive to EGCG
stimulation, we constructed 67LR-overexpressed cells (Fig. 1).
Using standard PCR protocols, cDNA encoding the human 67LR
(accession no. NM_002295) was cloned into the expression vector
pcDNA3.1(+) (Invitrogen, Carlsbad, CA). Full-length 67LR was
amplified by PCR using primers, 59-CGG TAC CAT GTC CGG
AGC CCT TGA TGT CCT GCA AAT G-39 and 59-GGC GGC
CGC TTA AGA CCA GTC AGT GGT TGC TCC TAC CCA-
39. The 67LR cDNA expression vector (non-tagged type) was
transfected into the HepG2 cells, a human hepatocellular
carcinoma cell line (ATCC, Rockville, MD), by electroporation.
Then, the clone with the neomycin resistance was selected and
used for further experiments. The 67LR-overexpressed HepG2
cells, human hepatoma cell line (ATCC), were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) (Cosmo Bio,
Tokyo, Japan) supplemented with 10% fetal bovine serum (FBS)
(Intergen, Purchase, NY), 100 U/ml penicillin G, 100 mg/ml
streptomycin, 25 mM HEPES buffer, and 44 mM NaHCO3 in
a humidified atmosphere with 5% CO2 at 37uC. For the cell
growth test, HepG2 cells were plated at a density of 2610
4 cells/
well (24-well culture plate) and allowed to adhere overnight. Each
67LR peptide (1 mM) and EGCG (1 mM) were mixed and
incubated at room temperature for 15 min in DMEM supple-
mented with 200 U/ml catalase and 5 U/ml SOD. Then the
mixture was added to the HepG2 cells in DMEM supplemented
with 2% FBS, 5 mg/ml BSA, 200 U/ml catalase and 5 U/ml
SOD. Following a subsequent incubation of 5 days, the cells in
each well were enumerated using a Cell Counter (Sysmex
Corporation, Tokyo, Japan). In this study, the cell death was not
observed in HepG2 cells treated with or without EGCG.
Recombinant Proteins of the Extracellular Domain of
Human 67LR and its Deletion Mutant
The extracellular domain (amino acid residues 102-295) of
human 67LR cDNA fragment, r-hLR102-295, with artificial
recognition sites of Kpn I and Not I at the 5’- and 3’-ends,
respectively, was amplified by PCR from pcDNA3.1(+)-human
67LR plasmid using sense: 59-C GGT ACC CGC TTC ACT
CCT GGA ACC TTC ACT AAC-39 and anti-sense: 59-GGC
GGC CGC TTA AGA CCA GTC AGT GGT TGC TCC TAC
CCA-39 primers. The resulting product was first ligated to the
pTARGET-vector, and transformed into E. coli cells JM109. For
construction of the deletion mutant (D161-170) of r-hLR102-295,r -
hLR102-295D161-170, a PCR method was carried out to delete
residues 161-170 by using a series of overlapping sense and
antisense primer pairs. Sequences of overlapping oligoprimers
were as follows: sense primer: 59-ATT GCC GTG GGT TTA
ATG TGG TGG ATG CTG-39 and anti-sense primer: 59-TAA
ACC CAC GGC AAT GTC CAC ATA GCG CAG-39. Using
these overlapping primers and the extracellular domain-amplifying
primers as mentioned above, two DNA fragments with the
overlapping end were obtained separately, and these fragments
were mixed to hybridize the overlapping ends to each other. The
fused DNA fragments were amplified by PCR using the
extracellular domain-amplifying primers. The resulting product,
r-hLR102-295D161-170, was ligated to the pTARGET-vector and
transformed into E. coli cells JM109.
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extracellular domain, r-hLR102-295, and the deletion mutant of the
161-170, r-hLR102-295D161-170. The gene fragments encoding
both r-hLR102-295 and r-hLR102-295D161-170 were placed under
the control of the T7 promoter on the expression plasmid pET-
30a(+) using Kpn I and Not I restriction sites. In these constructs,
the gene products were expected to carry a His-tag sequence
attached at the N-terminus. Expression in E. coli strain BL21 (DE3)
was induced overnight with 1 mM IPTG at 20uC as described by
the manufacturer. The E. coli cells were centrifuged at 5,000 rpm
for 10 min at 4uC. The cell pellet was washed several times in
Buffer A (50 mM Tris-HCl, pH 8.0, containing 200 mM NaCl)
and then sonicated in Buffer A. After centrifugation at 12,000 rpm
for 10 min, purification was carried out by using a His-bind resin
column (His Trap Chelating HP; GE Healthcare UK Ltd.,
Buckinghamshire, England), as described by the manufacturer.
The proteins were loaded onto the nickel-charged His-bind resin
column, previously equilibrated with 15 mL of the binding buffer
(20 mM Tris-HCl, pH 7.9, containing 5 mM imidazole and
0.5 M NaCl). After washing with two column volumes of the
wash buffer (20 mM Tris-HCl, pH 7.9, containing 60 mM
imidazole and 0.5 M NaCl), the adsorbed proteins were eluted
Figure 1. The relationship between the responsiveness of EGCG to the HepG2 cells and 67LR expression. A) Chemical structure of
green tea polyphenol EGCG. B) Western blot analysis of whole cell lysate from HepG2 cells using anti-LR antiserum (I) and anti-LR antibody F-18 (II). C)
To examine the expression of 67LR on cell membrane in HepG2 cells, both cytosolic and membrane fractions were prepared, and the 67LR were
detected by western blot analysis using anti-LR antiserum. This test was performed under reducing (2-Me (+)) or non-reducing (2-Me (2)) conditions.
2-Me indicates 2-mercaptoethanol. The lower panel displays protein levels from the same filter blotted again with the anti-b-actin antibody used as
a quantitative loading control. D) The cells transfected with either the empty vector (2) or the 67LR gene expression vector (+) were lysed and total
cellular protein was subjected to western blot analysis using the cell-surface LR-specific antibody MLuC5. The lower panel displays protein levels from
the same filter blotted again with the anti-b-actin antibody used as a quantitative loading control. E) Both transfected cells were fixed on the sensor
chip. The cell-surface binding of EGCG to immobilized 67LR-overexpressed or control HepG2 cells were measured using a surface plasmon resonance
(SPR) biosensor. EGCG was injected at a concentration of 10 mM for the time indicated interval in the figure. F) Both types of cells were treated with
1 mM EGCG for 5 days. The results are shown as the relative cell number to untreated control and the data presented are means 6 S.D. (n=3)
(Student’s t-test, **, p,0.01).
doi:10.1371/journal.pone.0037942.g001
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imidazole and 0.5 M NaCl). Then, this protein treated with
thrombin to remove the His tag, and further purified by gel
filtration on a Superose 12 column (106300 mm; GE Healthcare
UK Ltd., Buckinghamshire, England) equilibrated with Buffer A.
This purified protein was used for the neutralization activity assay.
The Cell-surface Binding Analysis of EGCG
Analysis of the interaction between EGCG and the 67LR-
overexpressed HepG2 cells was performed using the surface
plasmon resonance (SPR) biosensor SPR670 (Moritex Corp.,
Tokyo, Japan) as previously reported [6]. The cells were
immobilized on the sensor chip and the chip was equilibrated in
PBS. EGCG (10 mM) was added at a flow rate of 30 ml/min. The
cell-surface binding was measured at 25uC for 2 min followed by
dissociation. In this binding analysis, the SPR signal has
a characteristic behavior as follows. The elevation of the SPR
signal (the value of the changed resonance angle: resonance units)
was observed immediately after the injection of the ligands
(+EGCG). After the termination of the ligand exposure (-EGCG),
the perfusion buffer was changed to the ligand-free running buffer,
and the SPR signal was reduced by the dissociation of ligands
bound to the surface of the immobilized molecules, and the signal
converged to a constant level. For neutralizing experiments (Fig. 2),
prior to the EGCG injection to the cells, each 67LR peptide
(10 mM) and EGCG (10 mM) were mixed and pre-incubated at
room temperature for 15 min in PBS. This mixture was injected to
the cells and the binding strength was calculated by subtracting the
original binding signal (EGCG +67LR peptide) from the binding
signal obtained by injection of each 67LR peptide alone.
SDS-PAGE and Western Blotting
For validating the expression of 67LR in HepG2 cells
transfected with or without the 67LR expression vector (Fig. 1),
the total cellular level of 67LR expression from whole cell lysate
was measured by western blotting. The cells were lysed in cell lysis
buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1%
triton-X 100, 1 mM EDTA, 50 mM NaF, 30 mM Na4P2O7,
1 mM phenylmethylsulfonyl fluoride, 2.0 mg/ml aprotinin, and
1 mM pervanadate. Whole cell lysate was incubated at 4uC for
30 min and then centrifuged at 15,000 g for 30 min. The
supernatant or purified recombinant LR protein (Fig. 3) was
mixed with sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE) sample buffer. The mixture was loaded onto
a 10% SDS-PAGE gel, and electrophoresis was done under
reducing conditions (addition of 2-mercaptoethanol). For detection
of 67LR expression in the plasma membrane of HepG2 cells
(Fig. 1C), we separated cytoplasmic and membrane proteins by
using a membrane protein extraction kit (Fermentas, Burlington,
Canada), and the proteins were mixed with SDS-PAGE sample
buffer. These samples were loaded onto a 10% SDS-PAGE gel,
and electrophoresis was done under reducing or non-reducing
conditions. Visualization of all proteins on SDS-PAGE gel was
performed by Coomassie Brilliant Blue (CBB) staining (Fig. 3).
The sample after electrophoresis was then electrotransferred onto
a nitrocellulose membrane. The blotted nitrocellulose was probed
for 37LRP/67LR using anti-LR antibody (F18 or MLuC5) or
anti-LR antiserum, which was obtained from rat immunized with
synthesized peptide deduced from residues 161-170 of the human
67LR as previously reported [24]. The secondary antibodies used
were HRP-conjugated anti-rabbit IgG or anti-mouse IgM, and
detection was done using the ECL kit (GE Healthcare UK Ltd.,
Buckinghamshire, England).
Electrospray Ionization Mass Spectroscopy
The peptide solution was prepared by incubating each peptide
(5 mM) with or without EGCG (5 mM) in water at room
temperature for 15 min. The solution was dissolved in acetic acid
(1%)/ethanol (50%) solution, and the dissolved samples were
subjected to mass spectrometric analysis. Mass spectra of the
complexes were acquired on a LCQ Advantage ion trap mass
spectrometer (Thermo Fisher Scientific Inc., MT) fitted with an
ion source spray, electrospray ionization (ESI), working in the
positive ionization mode. The capillary was typically held at
4.5 kV and 270uC. The dissolved samples were continuously
infused into the ESI chamber at a flow rate of 100 ml/min.
Results
Construction of the Cells Capable of 67LR-mediated
Cellular Response to a Physiologically Relevant EGCG
The 67LR protein is believed to be derived from a smaller
precursor, the 37-kDa laminin receptor precursor (37LRP).
However, the precise mechanism by which cytoplasmic 37LRP
becomes cell-membrane-embedded 67LR is still unclear [25]. In
addition, expression patterns of 37LRP and 67LR in cancer cells
remain poorly understood. To examine the relationship between
37LRP/67LR and the bioactivity of the major green tea
polyphenol EGCG (Fig. 1A), we performed western blot analysis
of whole cell lysate from HepG2 cells, a human hepatocellular
carcinoma (Fig. 1B). The LR protein corresponding to approx-
imately 67 kDa, 67LR, was observed by using the anti-LR
antiserum (I), but the expression of the 37-kDa form (37LRP) was
not detected. On the other hand, the anti-LR antibody F18 (II)
was able to recognize the 37LRP, but not the 67LR. In HepG2
cells, both types of LR, the 37-kDa and 67-kDa forms, were
observed. Previously, we have reported that the level of total
cellular 67LR expression is strongly associated with the bioactiv-
ities of EGCG [6,16,26–29], and in particular, the lipid-raft-
associated 67LR on the plasma membrane plays an essential role
in governing both the localization of 67LR and the cellular
responsiveness of EGCG [26]. Therefore, it is important to
investigate the localization of 67LR in HepG2 cells to obtain
a better understanding of the cell-surface 67LR-mediated
bioactivities of EGCG. Here we revealed that the expression level
of 67LR in the plasma membrane fraction was much higher than
that in the cytoplasmic fraction (Fig. 1C). These results raise the
possibility that the plasma membrane 67LR may be responsible
for the cell-surface-mediated bioactivity of EGCG in HepG2 cells.
Until now, the most common explanations of the process of 67LR
are post-translational covalent modification or the formation of
very tightly associated homo- or hetero-dimers [30–32]. There are
two nucleophilic cysteine residues (143 and 163) in the extracel-
lular domain (102-295) of 37LRP/67LR. To examine whether or
not a Cys residue-mediated covalent modification, such as
disulfide bond formation, is involved in the formation of the cell-
surface 67LR in HepG2 cells, we performed western blot analysis
of the 67LR in the presence or absence of the reducing agent, 2-
mercaptoethanol (2-Me). The amount of 67LR was not affected
regardless of the presence or absence of the reducing agent
(Fig. 1C). This result suggests that a Cys residue-mediated disulfide
bond is not involved in the formation of the cell-membrane 67LR.
To further examine the relationship between the cell-surface
67LR-mediated cellular response and its interaction with EGCG
more sensitively, we constructed 67LR-overexpressed cells by
stable transfection of a 67LR gene expression vector into HepG2
cells. Western blot analysis of total cellular expression of 67LR
using the anti-LR antibody MLuC5, which can recognize the cell-
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EGCG [6,26], revealed that the expression of 67LR protein was
elevated in 67LR-overexpressed cells (Fig. 1D). To investigate
whether an increase in the expression of 67LR affects the
interaction of EGCG with the cells, we measured the cell-surface
binding of EGCG using a surface plasmon resonance (SPR)
biosensor. This technique has been increasingly used for real-time
analysis of the binding between solubilized molecules and
molecules immobilized on the surface of a biosensor chip without
any labeling by changes in the refractive index of a biospecific
surface [6,26,33–35]. SPR analysis revealed that the binding of
EGCG to the 67LR-overexpressed cells (+67LR) was higher than
that of the cells transfected with the empty vector (-67LR, Fig. 1E).
This result and the fact that 67LR is predominantly expressed in
the plasma membrane (Fig. 1C) suggest that the increase of
EGCG’s binding to the cells may be due to the elevated binding to
the cell-surface 67LR. We next investigated whether this binding
increase affected the inhibitory effect of EGCG on the pro-
liferation of HepG2 cells at the low concentration of 1 mM,
a physiologically relevant concentration [5]. As shown in Fig. 1F,
there was no alteration of the cell growth in control cells (-67LR)
upon treatment with EGCG, while a significant inhibition of
proliferation without inducing cell death was observed in the
67LR-overexpressed cells. These results indicate that the cell-
surface 67LR plays an essential role in the anti-cancer action of
a physiologically relevant concentration of EGCG. Thus, the
67LR-overexpressed HepG2 cells were used in the subsequent
experiments.
Neutralization Activity of Various Peptides Deduced from
the Extracellular Domain of 67LR Against the Cell-surface
Binding of EGCG
To identify the EGCG-binding site of the 67LR, we synthesized
ten kinds of 20-amino acid residue peptides deduced from the
extracellular domain corresponding to the 102-295 region of
human 67LR encoding 295-amino acids as shown in Fig. 2A. The
neutralizing effects of these peptides on the cell-surface binding of
EGCG were investigated using a SPR biosensor (Fig. 2B). EGCG
was shown to be able to bind to the 67LR-overexpressed HepG2
cells (blue line). As seen for the case of EGCG plus peptide (red
line), the binding strength was clearly reduced by peptide LR161-
180, IPCNNKGAHSVGLMWWMLAR, but the other peptides
did not reduce the interaction. These observations suggest that
EGCG binds to a specific 20-amino acid residue peptide
corresponding to the 161-180-residue stretch of the extracellular
region of the 67LR.
To further define the potential binding site for EGCG, we
conducted the same SPR assay using four kinds of the shorter
10-residue peptides deduced from the 161-180 residue region of
the 67LR (Fig. 2C). Only one peptide LR161-170, IPCNNK-
GAHS, resulted in a reduction of the cell-surface binding of
EGCG. We also performed an additional SPR test to clarify
whether the 10-amino acid length was required for the
neutralizing activity of the peptide LR161-170 (Fig. 2D). The
neutralizing activity of LR161-170 was inhibited by a single
amino acid deletion of the N- or C-terminus (I
161 or S
170)o f
LR161-170. These data indicate that a stretch of 10-amino acid
residues 161 to 170 (IPCNNKGAHS) in the extracellular region
of the 67LR is indispensable for neutralization activity against
the cell-surface binding of EGCG, and may contribute to the
EGCG-67LR interaction.
Estimation of the Potential Sensing Motif on the
Extracellular Domain of 67LR Contributed to the
Inhibitory Effect of EGCG on Cancer Cell Proliferation
We next examined the neutralizing activity of the 20-residue
peptides (Fig. 3A) for EGCG’s ability to inhibit the proliferation
of the 67LR-overexpressed HepG2. After pre-incubation of each
67LR peptide (1 mM) and EGCG (1 mM), this mixture was
added to the cells once at 0 day and further cultured for 5 days.
The results are shown as the relative cell number of EGCG- or
EGCG plus LR peptide-treated cells (closed bar) to EGCG-
nontreated control cells (open bar) at each mixture condition
(none or LR peptide). Addition of the peptide alone did not
affect the growth of the cells. Among the 20-amino acid residue
peptides tested, the peptide LR161-180 almost completely
abolished the anti-proliferative effect of EGCG, while the other
peptide did not. Thus, the 20-amino acid residue corresponding
to the 161-180-residue region of the extracellular domain of the
67LR may play an important role in the anti-proliferation
activity of EGCG.
To narrow the potential binding sequence for EGCG, an
additional cell proliferation assay using four kinds of the shorter
10-residue peptides deduced from the 161-180 residues of the
67LR was performed (Fig. 3B). Among the four peptides, only
peptide LR161-170 caused a reduction in the anti-proliferation
action of EGCG. Furthermore, the neutralizing activity of LR161-
170 was prevented by a single amino acid deletion at the N- or C-
terminus (I
161 or S
170) of LR161-170 (Fig. 3C). These results
implicate that a stretch of 10-amino acids from 161 to 170 in the
extracellular region of the 67LR is crucial for the neutralizing
activity towards the anti-proliferation as well as the cell-surface
binding.
To extrapolate these findings to the protein level, we
constructed the recombinant protein corresponding to the
extracellular domain sequence 102 to 295 of human 67LR, r-
hLR102-295, and the D161-170 deletion mutant, r-hLR102-
295D161-170, in an E. coli expression system. Two different
molecular weight bands were observed by both SDS-PAGE and
western blot analysis of recombinant LR protein r-hLR102-295
(Figs. 3D and 3E). The bands of the wild-type r-hLR102-295 were
approximately 33 and 35 kDa, and the corresponding bands of
the mutant r-hLR102-295D161-170 were approximately 32 and
34 kDa. Because the theoretical size of the 10-amino acid residue
fragment (161-170) is 1,040 Da, the difference in size between
the wild and mutant types, approximately 1 kDa, is reasonable,
indicating successful construction of the LR mutant, r-hLR102-
295D161-170. At least, such a band pattern of both types of r-
hLR (Figs. 3Dand 3E) suggests that two species of bands are not
intrinsic proteins from E. coli but extrinsic recombinant proteins.
Figure 2. The neutralization of the cell-surface binding of EGCG by peptides deduced from the extracellular domain of 67LR. A)
Synthetic peptide sequences deduced from the extracellular domain of 67LR. The neutralizing activity of these peptides for the cell-surface binding
was assayed. After incubation of EGCG (1 mM) with each peptide (1 mM): (B) 20-amino acid residue peptides, (C) 10-amino acid residue peptides, or
(D) 9-amino acid residue peptides (single amino acid deletion form of the N- or C-terminus of the peptide LR 161-170), interactions between these
EGCG-peptide mixtures and the 67LR-overexpressed HepG2 cells were measured by a SPR assay. Sensorgrams of the net binding of EGCG, which is
the value obtained from subtracting the peptide-binding signal from the total mixture-binding signal, are shown in panels B-D. The results are
represented as EGCG alone (blue line) and EGCG plus peptide (red line).
doi:10.1371/journal.pone.0037942.g002
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difference in modification or folding of recombinant LR protein
in E. coli. Further study is required for elucidating details of this
structural difference. Previously, Vana and Weiss reported that
the expression of the mutant LRP102-295::FLAG in mouse
neuroblastoma (N2a) and baby hamster kidney (BHK) cells,
respectively, resulted in a molecular weight of approximately
33 kDa [36]. Although the expression system, host and vector,
were different, the molecular size of this recombinant was very
similar to that of the r-hLR102-295 expressed by E. coli. After pre-
incubation of each recombinant LR protein, wild-type r-hLR102-
295 or mutant r-hLR102-295D161-170, or LR161-170 peptide with
or without EGCG, these mixtures were added to the 67LR-
overexpressed HepG2 cells. We evaluated the neutralizing
activity of the recombinant proteins towards EGCG’s ability to
inhibit the proliferation of HepG2 cells (Fig. 3F). The results are
shown as the relative cell number of EGCG-, EGCG plus LR
peptide-, or EGCG plus LR protein-treated cells (closed bar) to
EGCG-nontreated control cells (open bar) at each mixture
condition (none, LR peptide, or LR protein). Treatment with r-
hLR102-295 protein neutralized the inhibitory effect of EGCG
towards cancer cell growth to the same extent as the peptide
LR161-170. The deletion of residues 161-170 in r-hLR102-295
caused a significant reduction of the neutralizing activity of r-
hLR102-295. Taken together, these observations provide clear
evidence that residues 161-170, IPCNNKGAHS, in the extra-
cellular region of human 67LR are responsible for the 67LR-
mediated anti-cancer activity of a physiologically relevant
EGCG.
Characterization of the Functional Motif Responsible for
Exerting EGCG’s Activities
Several lines of evidence regarding the interaction between
EGCG and peptides or proteins suggest the importance of the
presence of nucleophilic residues [37,38]. To elucidate the
detailed mechanism for the interaction between EGCG and the
161-170 amino acid sequence on 67LR contributing to the
neutralization activity, we examined the nucleophilic basic
amino acid replacement of LR161-170, as shown in Fig. 4A.
Replacement of K
166 with other basic amino acids R or H did
not affect the neutralization activity such as the cell-surface
binding or the inhibitory effect on cancer cell growth (Figs. 4B
and 4C). On the other hand, replacement of K
166 with an
acidic or neutral amino acid such as E or S showed an
inhibition of both neutralization activities of the peptide (Figs. 4B
and 4C). These results suggest that a basic amino acid at
position 166 of LR161-170 is essential for exerting the
neutralization activities of the peptide.
In addition to these findings, we also investigated the in-
volvement of another basic amino acid H
169 in both neutralizing
activities. As shown in Figs. 4B and 4C, both neutralization
activities were inhibited by the replacement of H
169 with S.
Replacement of both K166 and H169 to S also caused the
inhibition of both neutralization activities. These facts indicate that
the existence of both K
166 and H
169 is indispensable for
neutralizing the cell-surface binding and the inhibitory effect on
cancer cell growth. Therefore, these two basic amino acids, K
166
and H
169, on the extracellular domain of human 67LR may
contribute to the EGCG-67LR interaction mediating functions of
EGCG.
In this study, we described a possible role of EGCG sensing
motif in human 67LR. However, it is unclear whether this role is
applicable to other organisms. The neutralization activity assay
using peptides derived from other organisms corresponding to the
human LR161-170 was performed. Although 4 species each have
a different peptide sequence in this region (Fig. 5A), both
neutralization activities were observed in all tested organisms
(Figs. 5B and 5C). These results implicate the possibility that 67LR
may be able to mediate the biological activity of EGCG in humans
as well as the other three organisms. Recently, EGCG has been
shown to form a covalent interaction with a nucleophilic cysteine
residue in a peptide or protein, suggesting that this interaction may
contribute to the biological activity, including the toxicology and
anti-tumor mechanism of EGCG in vivo [37,38]. However, our
findings that the replacement at position 163 from C to A did not
affect the neutralization activities indicated that C
163 was not
responsible for these effects. The results of Figs. 4 and 5 show the
essential role of the nucleophilic basic amino acid, K
166, in human
LR161-170 (IPCNNKGAHS). We also described the importance
of another basic acid at position 169 (Fig. 4). Furthermore, the
ability of the LR peptide was sustained even if the position of basic
amino acid changed from 169 to 168, as shown by the result of
oriza LR165-174 (IPANNKGKQS, Fig. 5). Therefore, two basic
amino acids within the region 166-169 in the human LR as well as
the 10-amino acid segment appear to be at least indispensable for
unraveling the structural properties of 67LR.
Although we described the characterization of the functional
motif responsible for exerting EGCG’s activities, the precise nature
of EGCG-LR peptide interaction, including whether it is a co-
valent or non-covalent complex or forms a monomer or dimer, still
remained unclear. To directly address this issue, we performed
mass spectrometric analysis, which can identify peptide-peptide or
low molecular weight compound-peptide interactions [37,39]
(Fig. 6). In the Cys residue-containing and neutralizing activity-
bearing peptide LR161-170, the mass spectrum revealed pro-
tonated ion peak at m/z 520.7, corresponding to the doubly
protonated monomer peptide peak [LR161-170+2H]
2+ (Fig. 6A).
In contrast, a dimer peptide peak, which was caused by formation
of a disulfide bond between two Cys
163 residues, was not observed
at m/z 1039.4 [Dimer (2LR161-170-2H)+2H]
2+. Although further
study is necessary, the results of the Cys residue-targeted analysis,
both LR peptide (Fig. 6) and 67LR protein (Fig. 1C), provide the
Figure 3. The neutralization of the inhibitory effect of EGCG on cancer cell growth by peptides deduced from the extracellular
domain of 67LR. After pre-incubation of EGCG (1 mM) with each peptide (1 mM): (A) 20-amino acid segment peptides, (B) 10-amino acid segment
peptides, or (C) 9-amino acid segment peptides (single amino acid deletion form of the N- or C-terminus of the peptide LR 161-170), the 67LR-
overexpressed HepG2 cells were treated with these mixtures for 5 days and the cell number was assessed. The results, EGCG plus peptide (closed
bar), are shown as the relative cell number to the EGCG-nontreated control (open bar), and the data presented are the means 6 S.D. (n=3) (Student’s
t-test, *, p,0.05, **, p,0.01, ***, p,0.001). D) SDS-PAGE of recombinant LR (r-hLR102-295 and the mutant r-hLR102-295D161-171 expressed in E. coli).
The lanes of Wild and D161-171 are the wild-type r-hLR102-295 and the mutant r-hLR102-295D161-171, respectively. Molecular mass markers (in kDa) are
indicated at the left. E) Western blot analysis of the recombinant LR was performed by using the anti-LR antibody F18. F) The effect of r-hLR102-295 and
the mutant r-hLR102-295D161-170 on the cancer cell growth inhibition by EGCG. After incubation of each r-hLR protein or LR161-170 peptide with or
without EGCG, HepG2 cells were treated with these mixtures for 5 days and the cell number was assessed. The results are shown as the relative cell
number of EGCG-, EGCG plus LR peptide-, or EGCG plus LR protein-treated cells (closed bar) to the EGCG-nontreated control cells (open bar) under
each mixture condition (none, LR peptide, or LR protein), and the data presented are the means 6 S.D. (n=3) (Student’s t-test, ***, p,0.001).
doi:10.1371/journal.pone.0037942.g003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37942Figure 4. Importance of basic amino acid resides in the EGCG sensing motif for EGCG’s activity. A) Basic amino acid replacements of
LR161-170. Replaced peptide sequences are shown in the list. B) The neutralizing activity of several basic amino acid-replaced LR161-170 segments
for the cell-surface binding of EGCG. After incubation of EGCG with each peptide at a molar ratio of 1:1 in PBS, interactions between these EGCG-
peptide mixtures and the cells were measured by a SPR assay. Sensorgrams of net binding of EGCG, which is the value of the subtracted peptide-
binding signal from the total mixture-binding signal, are shown. The results are represented as EGCG alone (blue line) and EGCG plus deletion mutant
of LR161-170 (red line). C) The neutralizing activity of several basic amino acid-replaced LR161-170 segments on the EGCG-induced inhibition of
cancer cell growth. After incubation of EGCG with each peptide, the 67LR-overexpressed HepG2 cells were treated with the mixtures for 5 days and
the cell number was assessed. The results, EGCG plus peptide (closed bar), are shown as the relative cell number to the EGCG-nontreated control
(open bar), and the data presented are the means 6 S.D. (n=3) (Student’s t-test, *, p,0.05, **, p,0.01).
doi:10.1371/journal.pone.0037942.g004
Figure 5. A possible role of LR161-170 motif derived from other organisms for exerting of EGCG’s activities. A) LR161-170 motif of
other organisms. B) The neutralizing activity of LR161-170 derived from other organisms for the cell-surface binding of EGCG. After incubation of
EGCG with each peptide at a molar ratio of 1:1 in PBS, interactions between these EGCG-peptide mixtures and the 67LR-overexpressed HepG2 cells
were measured by a SPR assay. Sensorgrams of the net binding of EGCG, which is the value of the subtracted peptide-binding signal from the total
mixture-binding signal, are shown. The results are represented as EGCG alone (blue line) and EGCG plus deletion mutant of LR161-170 (red line). C)
The neutralizing activity of LR161-170 derived from other organisms on the EGCG-induced inhibition of cancer cell growth. After incubation of EGCG
with each peptide, HepG2 cells were treated with the mixtures for 5 days and the cell number was assessed. The results, EGCG plus peptide (closed
bar), are shown as the relative cell number to the EGCG-nontreated control (open bar), and the data presented are the means 6 S.D. (n=3) (Student’s
t-test, *, p,0.05).
doi:10.1371/journal.pone.0037942.g005
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37942possibility that the 67LR is not due to the homo-dimerization of
37LRP directly mediated through the Cys
163 residue within
residues 161-170. We also analyzed the mixture of LR161-170
peptide with EGCG (Fig. 6B). The mass spectrum showed an ion
peak at m/z 749.7 corresponding to the non-covalent ion peak of
chemically non-altered EGCG (intact form)-monomer peptide
complex [LR161-170+EGCG+2H]
2+. However, the ion peak of
a EGCG-dimer peptide complex was not detected at m/z 1268.5,
corresponding to [Dimer (2LR161-170-2H)+EGCG+2H]
2+.
These data suggest that mixing EGCG with the peptide does
not induce the chemical alteration of EGCG, and instead a non-
covalent complex, based on intact EGCG-monomer LR peptide
interactions, may play an essential role in the EGCG-67LR
interaction and bioactivity of EGCG. Although previous studies
have reported the covalent interaction between EGCG and
a certain Cys residue-containing peptide, EGCG-29-Cys-peptide
[37], a covalent complex peak [(LR161-170+EGCG-2H)+2H]
2+
was not observed at m/z 748.7 (Fig. 6B, inset). Therefore, these
mass spectral data indicated that EGCG could not form a covalent
complex with the monomer LR161-170 peptide. As shown in
Fig. 5, soy LR168-177 peptide corresponding to the human
LR161-170 is lacking a Cys residue but still has neutralizing
activity. Mass spectrometric analysis revealed an ion peak of
chemically non-altered EGCG (intact form)-monomer peptide
complex [Soy LR168-177+EGCG+2H]
2+ at m/z 762.3 (Fig. 6C).
This data also support the idea that the Cys residue is not involved
in the EGCG-LR peptide interaction, and thus this nucleophilic
residue is not responsible for the neutralizing activity of the
peptide. Taken together, the binding nature of EGCG to residues
161-170 of 67LR may play an important role in the cell-surface
67LR-mediated bioactivity of EGCG. The proposed role of the
EGCG-functional motif may be further defined as more structural
experimental evidence is obtained.
Discussion
The evolutionary analysis of 67LR has suggested that the
acquisition of the laminin-binding capability is linked to the
palindromic sequence LMWWML, corresponding to residues
173–178 [11]. Intriguingly, this segment is proximate to the
EGCG-functional domain, residues 161-170. We have previously
reported that a laminin retreatment partially inhibited the binding
of EGCG to the 67LR and treatment with the cell-surface LR-
specific antibody MLuC5, capable of inhibiting laminin binding to
67LR, prevented EGCG’s abilities such as its cell-surface binding
and inhibition of cancer cell growth [6]. Thus, the position
proximity between the EGCG- and laminin-binding motifs may
provide a possible explanation, steric hindrance caused by laminin
or antibody, for the inhibition of the functions of EGCG. In spite
of the proximity between both motifs, laminin did not show an
inhibitory effect on cancer cell growth in a similar fashion as
EGCG [16]. These facts imply that our proposed EGCG sensing
motif may not be easily regulated by a proximal region-specific
ligand. From the crystal structure of 67LR, residues 161-180 have
been shown to comprise the linker between b-sheet strand 7 (b7)
and a helix E (aE) [23]. The only portion of this sequence that was
solvent-accessible was suggested to be residues 165-169 in the b7-
aE linker. It was speculated that such residues might be exposed
by a conformational change of the C-terminal tail of the receptor.
Although these observations may provide a possible rationale for
the accessibility of EGCG to the 161-170 region of 67LR, further
structural studies are required to elucidate the details of the
EGCG-67LR interaction.
The multifunctional 67LR is known to have a role as a receptor
for viruses such as Sindbis virus, Dengue virus, adeno-associated
virus, and Venezuelan equine encephalitis virus as well as prion
protein [9,18–21,40]. A hallmark in prion diseases is the
conformational transition of the cellular prion protein (PrP
c) into
a pathogenic conformation, designated scrapie prion protein
PrP
Sc, which is the essential constituent of infectious prions.
Recently, EGCG has been reported to interfere with the stress-
protective activity of PrP
c and the formation of PrP
Sc in scrapie-
infected N2a cells [41]. Interestingly, the 37-kDa/67-kDa laminin
receptor has found to be involved in prion functions, and a yeast
two-hybrid system showed that the direct PrP-binding site was
located between aa 161-179 of the 37-kDa laminin receptor [32].
Thus, our identification of a putative EGCG-binding sequence has
also implications for elucidating the potential molecular mechan-
isms into how EGCG might ameliorate prion diseases.
Protein interactions with EGCG have been proposed to be
involved in various bioactivities. Many proteins have been
identified as EGCG-binding targets mediating anti-cancer action
[5]. Nonetheless, in the most cases, the precise mechanism by
which the binding of EGCG to proteins regulates protein function
remains to be elucidated. In contrast, the present study is the first
evidence providing structural information about the functional
domain of 67LR responsible for mediating the anti-cancer action
of a physiologically relevant EGCG (1 mM). Previously, the 67LR
has been shown to be responsible for anti-allergic effects of EGCG
in basophils [26,34]. In preadipocytes, EGCG has been reported
to mediate anti-insulin signaling via the 67LR pathway [42].
Furthermore, protection of dystrophic muscle cells with EGCG
correlated with improved glutathione balance and increased
expression of 67LR [43]. Most currently, we found that
a physiologically relevant EGCG downregulates Toll-like re-
ceptor-2/4 signaling through 67LR in macrophages [28,29]. In
addition to these 67LR-mediated cellular responses, chemical
modifications of EGCG based on the structural information for its
binding molecule have received considerable attention as potential
strategies for enhancing biological activities of EGCG [44,45].
Thus, the structural characterization of 67LR will contribute to
a better understanding of how EGCG interacts with 67LR and
should help in the design of therapeutics that can mimic EGCG-
67LR interactions in preclinical and clinical settings of cancer as
well as immune responses, muscle and adipocyte functions.
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containing peptide human LR161-170 and (B) its mixture with EGCG. B) An inset is the figure zooming in the relevant peak to see the difference
between non-covalent (m/z 749.7 [LR161-170+EGCG+2H]
2+) and covalent binding (m/z 748.7 [(LR161-170+EGCG-2H)+2H]
2+). C) Mass spectrum of the
mixture of the Cys residue-lacking peptide soy LR168-177 with EGCG. [LR161-170+2H]
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complexes).
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